3
Oct 24 (Reuters) – Parabilis Medicines Inc: * PARABILIS MEDICINES PRESENTS UPDATED PHASE 1/2 DATA FOR ZOLUCATETIDE DEMONSTRATING COMPELLING EFFICACY AND FAVORABLE SAFETY AND TOLERABILITY PROFILE IN
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
